---
title: "12 Health Care Stocks Moving In Tuesday's Pre-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298319801.md"
description: "During Tuesday's pre-market session, several healthcare stocks showed significant movement. Gainers included iSpecimen (up 22.7%), Bluejay Diagnostics (up 22.53%), Pharvaris (up 19.12%), Roivant Sciences (up 18.49%), Atara Biotherapeutics (up 9.83%), and Jin Medical International (up 9.08%). Conversely, losers featured Dyne Therapeutics (down 28.8%), bioAffinity Technologies (down 24.69%), Onconetix (down 18.63%), Lexaria Bioscience (down 17.96%), Jaguar Health (down 17.25%), and Pomdoctor (down 15.67%)."
datetime: "2026-09-08T12:05:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298319801.md)
  - [en](https://longbridge.com/en/news/298319801.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298319801.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Tuesday's Pre-Market Session

### Gainers

-   **iSpecimen** (NASDAQ:ISPC) stock increased by 22.7% to $1.89 during Tuesday's pre-market session. The company's market cap stands at $3.8 million.
-   **Bluejay Diagnostics** (NASDAQ:BJDX) shares moved upwards by 22.53% to $1.02.
-   **Pharvaris** (NASDAQ:PHVS) stock rose 19.12% to $41.99. The company's market cap stands at $2.4 billion.
-   **Roivant Sciences** (NASDAQ:ROIV) stock rose 18.49% to $41.39. The company's market cap stands at $25.2 billion.
-   **Atara Biotherapeutics** (NASDAQ:ATRA) stock moved upwards by 9.83% to $10.72. The company's market cap stands at $97.9 million.
-   **Jin Medical International** (NASDAQ:ZJYL) shares increased by 9.08% to $2.27. The market value of their outstanding shares is at $16.2 million.

### Losers

-   **Dyne Therapeutics** (NASDAQ:DYN) shares fell 28.8% to $17.3 during Tuesday's pre-market session. The company's market cap stands at $4.5 billion.
-   **bioAffinity Technologies** (NASDAQ:BIAF) stock declined by 24.69% to $11.5. The company's market cap stands at $9.1 million.
-   **Onconetix** (NASDAQ:ONCO) shares fell 18.63% to $0.83. The market value of their outstanding shares is at $4.4 million.
-   **Lexaria Bioscience** (NASDAQ:LEXX) shares fell 17.96% to $11.61. The company's market cap stands at $23.3 million.
-   **Jaguar Health** (NASDAQ:JAGX) stock fell 17.25% to $0.49. The company's market cap stands at $3.0 million.
-   **Pomdoctor** (NASDAQ:POM) stock declined by 15.67% to $0.7. The company's market cap stands at $7.6 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [BJDX.US](https://longbridge.com/en/quote/BJDX.US.md)
- [ROIV.US](https://longbridge.com/en/quote/ROIV.US.md)
- [ONCO.US](https://longbridge.com/en/quote/ONCO.US.md)
- [LEXX.US](https://longbridge.com/en/quote/LEXX.US.md)
- [BIAF.US](https://longbridge.com/en/quote/BIAF.US.md)
- [ATRA.US](https://longbridge.com/en/quote/ATRA.US.md)
- [DYN.US](https://longbridge.com/en/quote/DYN.US.md)
- [PHVS.US](https://longbridge.com/en/quote/PHVS.US.md)
- [ZJYL.US](https://longbridge.com/en/quote/ZJYL.US.md)
- [JAGX.US](https://longbridge.com/en/quote/JAGX.US.md)
- [POM.US](https://longbridge.com/en/quote/POM.US.md)
- [ISPC.US](https://longbridge.com/en/quote/ISPC.US.md)
- [BIAFW.US](https://longbridge.com/en/quote/BIAFW.US.md)
- [LEXXW.US](https://longbridge.com/en/quote/LEXXW.US.md)

## Related News & Research

- [BioAffinity Technologies Stock Surges Following Hong Kong Patent Grant](https://longbridge.com/en/news/299359121.md)
- [Onco-Innovations Converts Insider Debt to Equity in $481,694 Share Settlement](https://longbridge.com/en/news/299240474.md)
- [Pharvaris Chief Technical Ops Officer Sold Shares Worth Over $1.7M](https://longbridge.com/en/news/299351805.md)
- [Pharvaris Chief Commercial Officer Wim Souverijns sells USD 1.02 million in common shares](https://longbridge.com/en/news/299218855.md)
- [Roivant Sciences director Meghan FitzGerald reports $203,159 common share sale](https://longbridge.com/en/news/299370950.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**